Go

Breaking News on Supplements & Nutrition - North America EU edition

All feeds

Headlines > Regulation

News in brief

FDA raps supplements firm over drug claims

16-Sep-2009

Related topics: Regulation

The Food and Drug Administration has told Californian-based supplements manufacturer, EFT Biotech Holdings, claims it has been making about products such as Colostrum #3008, GlucoBalance #3017 and VisionPlus #3012 are drug-like and must be ceased.

“The therapeutic claims on your website establish that these products are drugs because they are intended for use in the cure, mitigation, treatment, or prevention of disease. The marketing of these products with these claims violate the Act,” FDA said in its warning letter to the company.

It listed 37 medicinal claims for 11 products that were making drug-like claims without having drug approval.

A product called 2006 Celprotect I was also found to be adulterated with 5.2ug of lead (pb)/gram,leading to daily consumption of 12mg if consumers followed the dosage advice that came with the product.

The FDA said this level was dangerous to children under the age of seven.